Markets:

Overview

News

Currencies

International

Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

73.43 -1.04 (-1.40%)

Streaming Delayed Price Updated: 3:57 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Alcon Earnings Preview ↗

May 12, 2025

Via Benzinga

Alcon Announces Results of 2025 Annual General Meeting

May 06, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS

April 25, 2025

From Alcon Inc. Investors

Via Business Wire

3 Stocks Upping Dividends & 1 With A 10% Special Dividend Yield

April 16, 2025

Via MarketBeat

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Alcon Analysts Increase Their Forecasts After Q2 Results ↗

August 22, 2024

Via Benzinga

Alcon Publishes Agenda for 2025 Annual General Meeting

April 04, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

April 02, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

March 26, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

March 25, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Eyes Surgical Edge With LENSAR Buyout: Details ↗

March 24, 2025

Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser technologies, boosting Alcon's offerings in femtosecond laser-assisted cataract...

Via Benzinga

Alcon Agrees to Acquire LENSAR, Inc.

March 24, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon to Host 2025 Capital Markets Day

March 13, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters

February 27, 2025

From Alcon Canada

Via Business Wire

Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation

February 25, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet

February 24, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension

February 19, 2025

From Alcon Inc. Investors

Via Business Wire

Apple To $253? Here Are 10 Top Analyst Forecasts For Friday ↗

January 24, 2025

Via Benzinga

Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference

December 31, 2024

From Alcon Inc. Investors

Via Business Wire

Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 17, 2024

Via Benzinga

Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation

November 12, 2024

From Alcon Inc. Investors

Via Business Wire

Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

November 07, 2024

From Alcon Inc. Investors

Via Business Wire

Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance

October 15, 2024

From Alcon Inc. Investors

Via Business Wire

Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

September 25, 2024

The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.

Via MarketBeat

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 12, 2024

Via Benzinga

ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q2 2024 ↗

August 20, 2024

ALC stock results show that Alcon beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses

August 20, 2024

From Alcon Inc. Investors

Via Business Wire

S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone ↗

August 20, 2024

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.